Clinical Studies

Therapeutic potential of Panax ginseng and ginsenosides in the treatment of chronic obstructive pulmonary disease

Posted by Michael Burmeister on

Chronic obstructive pulmonary disease (COPD) is a major global health burden and will become the third largest cause of death in the world by 2030. Panax ginseng has a long history of use in Chinese medicine for respiratory conditions, including asthma and COPD ... Panax ginseng protects against oxidative stress by increasing anti-oxidative enzymes and reducing the production of oxidants.

Read more →

Ginsenosides from Korean Red Ginseng ameliorate lung inflammatory responses: inhibition of the MAPKs/NF-κB/c-Fos pathways

Posted by Michael Burmeister on

Ginseng (steamed and dried white ginseng, Panax ginseng Meyer) is well known for enhancing vital energy and immune capacity and for inhibiting cancer cell growth. Some clinical studies also demonstrated a therapeutic potential of ginseng extract for treating lung inflammatory disorders ... Certain ginsenosides inhibit lung inflammatory responses by interrupting these signaling molecules and they are potential therapeutics for inflammatory lung diseases.

Read more →

Local Study Examines Effect On Diabetes

Posted by Michael Burmeister on

"If ginseng turns out to be a viable treatment option," he said, "it may give patients and healthcare providers additional adjunctive treatment when designing a management plan."

Read more →

Ginseng Fights Fatigue in Cancer Patients, Mayo Clinic-Led Study Finds

Posted by Michael Burmeister on

"After eight weeks, we saw a 20-point improvement in fatigue in cancer patients, measured on a 100-point, standardized fatigue scale," Dr. Barton says. The herb had no apparent side effects, she says.

Read more →

Ginseng Extract Shows Promise For Diabetes & Obesity

Posted by Michael Burmeister on

Read more →